FDA Approved: ELELYSO — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for ELELYSO (taliglucerase alfa) submitted by Pfizer Laboratories Div Pfizer Inc, under BLA022458.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease

Drugs mentioned

• ELELYSO (TALIGLUCERASE ALFA)

Snippet

SUPPL AP for ELELYSO (TALIGLUCERASE ALFA)